Moneycontrol PRO
you are here: HomeNewsIndia

COVID-19 vaccination | Delhi doesn't have enough doses for 18-44 age group: Satyendar Jain

Delhi Health Minister said that the manufactures are yet to provide a schedule of vaccine supply to the government.

April 29, 2021 / 04:06 PM IST
Representational image

Representational image

Delhi Health Minister Satyendar Jain on April 29 said the city does not have sufficient doses of vaccine to begin inoculation of those in the 18-44 age group. Orders have been placed with manufacturers for COVID-19 vaccines, Jain said, adding that the preparations to give jabs to this category have been completed.

"At present, we don't have vaccines. We have requested the companies to provide it," Jain said when asked if there were enough vaccines available for the 18-44 age group.

Track this LIVE blog for latest update on coronavirus pandemic

The authorities are yet to decide whether the vaccinations will begin for the 18-45 age group from May 1. "We will tell you in a day or two," the minister said on starting the inoculation drive for this category.

He also said that the manufacturers are yet to provide a schedule of vaccine supply to the Delhi government.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Read: Free COVID-19 vaccine for those age above 18 years in Delhi: CM Arvind Kejriwal

Chief Minister Arvind Kejriwal had earlier announced free vaccine for all aged above 18 in Delhi. He had said his government had approved the procurement of 1.34 crore vaccine doses from various manufacturers.

The Delhi government on April 29 released revised cumulative coronavirus figures for the city, raising the case tally by 44,350 and fatalities by 761 than previously reported.

In the revised figures, the state government has put the number of cases at 10,98,051 and deaths at 15,377.

The cumulative positivity rate has also been revised upwards from 6.20 percent to 6.46 percent. The number of recoveries too has been revised up to 9,82,922 from 9,39,333.

Authorities on April 28 reported 368 COVID-19 deaths and 25,986 cases with a positivity rate of 31.76 percent in Delhi. It was the seventh day on the trot that the city recorded over 300 deaths due to coronavirus.

(With inputs from PTI)

Click here for Moneycontrol's full coverage of the COVID-19 outbreak

Moneycontrol News
first published: Apr 29, 2021 04:06 pm